Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. | 24858205 | Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, Giles FJ, Wang-Johanning F, Ambs S, Glynn SA | Carcinogenesis | 2014 | PLCO |
| Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. | 22711227 | Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC | Head Neck | 2013 | PLCO |
| Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 22736219 | Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B | Cancer | 2013 | PLCO |
| Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial. | 23262924 | Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN | Obstet Gynecol | 2013 | PLCO |
| A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. | 23295781 | Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L | Pancreas | 2013 | PLCO |
| Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. | 22893105 | Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H | Cancer | 2013 | PLCO |
| Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. | 23065684 | Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD | Int. J. Cancer | 2013 | PLCO |
| An aggregated analysis of hormonal factors and endometrial cancer risk by parity. | 23280123 | Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV | Cancer | 2013 | PLCO |
| Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. | 23112111 | Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutr… | Cancer Causes Control | 2013 | PLCO |
| Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. | 23171878 | Chaturvedi AK, Moore SC, Hildesheim A | Am. J. Epidemiol. | 2013 | PLCO |
| Results of initial low-dose computed tomographic screening for lung cancer. | 23697514 | National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S | N. Engl. J. Med. | 2013 | NLST |
| National lung screening trial: variability in nodule detection rates in chest CT studies. | 23592767 | Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J | Radiology | 2013 | NLST |
| Selection criteria for lung-cancer screening. | 23425165 | Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD | N. Engl. J. Med. | 2013 | NLST |
| Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up. | 23280348 | Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA | Cancer | 2013 | NLST |
| Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. | 23513242 | Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS | Radiology | 2013 | NLST |
| Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: the model used by the American College of Radiology arm of the National Lung Screening Trial. | 22982342 | Gareen IF, Sicks JD, Jain AA, Moline D, Coffman-Kadish N | Contemp Clin Trials | 2013 | NLST |
| Targeting of low-dose CT screening according to the risk of lung-cancer death. | 23863051 | Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA | N. Engl. J. Med. | 2013 | NLST |
| Effective dose assessment for participants in the National Lung Screening Trial undergoing posteroanterior chest radiographic examinations. | 23789668 | Kruger R, Flynn MJ, Judy PF, Cagnon CH, Seibert JA | AJR Am J Roentgenol | 2013 | NLST |
| The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. | 24037918 | Pinsky PF, Church TR, Izmirlian G, Kramer BS | Cancer | 2013 | NLST |
| ROC curves for low-dose CT in the National Lung Screening Trial. | 24009092 | Pinsky PF, Gierada DS, Nath H, Kazerooni EA, Amorosa J | J Med Screen | 2013 | NLST |